Skip to content

Clinical trials

Urinary Bladder Neoplasms trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Urinary Bladder Neoplasms Country / region: Taiwan Clear all

40 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20131
20141
20154
20162
20186
20191
20205
20216
20222
20235
20242
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting13
Completed13
Recruiting8
Terminated4
Enrolling by invitation1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca5
Hoffmann-La Roche3
Janssen Research & Development, LLC3
Merck Sharp & Dohme LLC3
Pfizer3
Astellas Pharma Global Development, Inc.2
EMD Serono Research & Development Institute, Inc.2
Eli Lilly and Company2
National Taiwan University Hospital2
Seagen, a wholly owned subsidiary of Pfizer2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Urinary Bladder Neoplasms40
Carcinoma, Transitional Cell11
Carcinoma, Non-Small-Cell Lung7
Stomach Neoplasms7
Ovarian Neoplasms6
Esophageal Neoplasms5
Lung Neoplasms5
Squamous Cell Carcinoma of Head and Neck5
Neoplasms4
Non-Muscle Invasive Bladder Neoplasms4

Trials

Showing 76 to 40 of 40. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.